On Wednesday, Kohl’s Corporation (NYSE:KSS)’s shares inclined 1.11% to $62.77.
Kohl’s Corporation (KSS) declared Michelle Gass has been designated to the newly created principal officer position of Chief Merchandising and Customer Officer. In this new capacity, Gass has assumed oversight of all of Kohl’s merchandising, planning and allocation, and product development functions. She will continue to report to Kevin Mansell, Kohl’s chairman, chief executive officer and president. Gass retains direct responsibility for Kohl’s overall customer engagement strategy, counting the company’s marketing, public relations and social media efforts. In light of Gass’ new responsibilities, Mansell has assumed direct oversight of the company’s digital and e-commerce strategies and operations.
Kohl’s has commenced an external search for a Chief Operating Officer, a newly created principal officer position. The chief operating officer will have direct responsibility for the company’s store operations, logistics and supply chain network, information and digital technology, e-commerce strategy and operations, and store construction and design. In the interim, these functions are all being overseen by Mansell. Along with Gass, the chief operating officer is predictable to be a potential candidate to succeed Mansell upon his eventual retirement.
Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers. The company also sells its products online at Kohls.com and through mobile devices.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s shares gained 1.52% to $40.16.
ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, recently declared that it will present at the JMP Securities Life Sciences Conference on Wednesday, June 24, 2015, at 11:00 a.m. Eastern Time in New York City.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which accomplished the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis; is in Phase II study for Alzheimer’s disease psychosis; and has accomplished Phase II trial for the treatment of schizophrenia.
At the end of Wednesday’s trade, Prologis Inc (NYSE:PLD)‘s shares surged 0.51% to $39.40.
Prologis Inc (PLD) has finally accomplished the acquisition of KTR Capital Partners’ (KTR) real estate assets and operating platform in addition to its associates for $5.9 billion. The buyout is predictable to provide a strong boost to the company’s position in the U.S. target markets. Following the acquisition, the company has also raised its core funds from operations (“FFO”) outlook for 2015.
Prologis’ share of the accomplished purchase was valued at around $3.2 billion. That comprised of $2.6 billion in cash, $400 million in secured mortgage debt assumption and issuance of $202 million in common limited partnership units in Prologis, L.P.
The acquisition took place through Prologis U.S. Logistics Venture (“USLV”) in a 55–45 merged joint venture with Norges Bank Investment Administration (NBIM), which is the manager of the Norwegian Government Pension Fund Global. The deal brought around 60 million square feet of operating portfolio to Prologis. It also comprised of 3.6 million square feet of development-in-progress space in addition to a well-located land bank that offers a build-out potential of 6.7 million square feet.
Prologis anticipates the deal to be accretive to its annual core FFO by around 9 cents per share. This led to an upward revision in its 2015 core FFO guidance range to $2.16–$2.22 per share from $2.07–$2.13 per share guided earlier, representing year-over-year growth of over 16% at the midpoint.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, administration, and leasing of industrial distribution and retail properties. It was formerly known as Security Capital Investment Trust. Prologis Inc. was formed in 1991 and is based in San Francisco, California with an additional office in Denver, Colorado.
Lennar Corporation (NYSE:LEN), ended its Wednesday’s trading session with -1.18% loss, and closed at $47.00.
Lennar Corporation (LEN) declared recently that the Company will release earnings for the second quarter ended May 31, 2015 before the market opens on June 24, 2015. Additionally, the Company will hold a conference call on June 24, 2015 at 11:00 a.m. Eastern Time.
Lennar Corporation, together with its auxiliaries, engages in the homebuilding activities in the United States. The company operates through Homebuilding East, Homebuilding Central, Homebuilding West, Homebuilding Southeast Florida, Homebuilding Houston, Financial Services, Rialto, and Lennar Multifamily segments. Its homebuilding activities primarily comprise the construction and sale of single-family attached and detached homes to first-time, move-up, and active adult homebuyers, in addition to the purchase, development, and sale of residential land.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
